🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Septerna sees $11.7 million in stock purchases by Third Rock Ventures

Published 10/29/2024, 05:00 AM
SEPN
-

BOSTON—Third Rock Ventures, a prominent life sciences venture capital firm, has made significant acquisitions of Septerna, Inc. (NASDAQ:SEPN) stock, according to a recent SEC filing. The firm purchased a total of 650,000 shares of Septerna's common stock at a price of $18 per share, amounting to a $11.7 million investment.

These transactions were executed by various entities associated with Third Rock Ventures, including Third Rock Ventures V, L.P. and Third Rock Ventures VI, L.P., among others. The purchases were made on October 28, 2024, and reflect the firm's continued interest in the pharmaceutical preparations sector, where Septerna operates.

The filing also detailed the conversion of Series A and B Preferred Stock into common stock, though these conversions did not involve any cash transactions. The preferred shares were converted at a one-for-8.6103 basis upon the closing of Septerna’s initial public offering.

Third Rock Ventures has been a major player in the life sciences investment landscape, often focusing on early-stage companies with innovative approaches to healthcare. The latest acquisitions further cement their position as a key stakeholder in Septerna, which is based in South San Francisco, California.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.